A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers - MycoMedica Life Sciences PBC (ClinicalTrials.gov, 2026)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com